Correlation Between Ocular Therapeutix and Inozyme Pharma
Can any of the company-specific risk be diversified away by investing in both Ocular Therapeutix and Inozyme Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ocular Therapeutix and Inozyme Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ocular Therapeutix and Inozyme Pharma, you can compare the effects of market volatilities on Ocular Therapeutix and Inozyme Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ocular Therapeutix with a short position of Inozyme Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ocular Therapeutix and Inozyme Pharma.
Diversification Opportunities for Ocular Therapeutix and Inozyme Pharma
-0.15 | Correlation Coefficient |
Good diversification
The 3 months correlation between Ocular and Inozyme is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Ocular Therapeutix and Inozyme Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inozyme Pharma and Ocular Therapeutix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ocular Therapeutix are associated (or correlated) with Inozyme Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inozyme Pharma has no effect on the direction of Ocular Therapeutix i.e., Ocular Therapeutix and Inozyme Pharma go up and down completely randomly.
Pair Corralation between Ocular Therapeutix and Inozyme Pharma
Given the investment horizon of 90 days Ocular Therapeutix is expected to generate 0.89 times more return on investment than Inozyme Pharma. However, Ocular Therapeutix is 1.13 times less risky than Inozyme Pharma. It trades about -0.3 of its potential returns per unit of risk. Inozyme Pharma is currently generating about -0.73 per unit of risk. If you would invest 1,137 in Ocular Therapeutix on August 28, 2024 and sell it today you would lose (228.00) from holding Ocular Therapeutix or give up 20.05% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ocular Therapeutix vs. Inozyme Pharma
Performance |
| Timeline |
| Ocular Therapeutix |
| Inozyme Pharma |
Ocular Therapeutix and Inozyme Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ocular Therapeutix and Inozyme Pharma
The main advantage of trading using opposite Ocular Therapeutix and Inozyme Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ocular Therapeutix position performs unexpectedly, Inozyme Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inozyme Pharma will offset losses from the drop in Inozyme Pharma's long position.| Ocular Therapeutix vs. CytomX Therapeutics | Ocular Therapeutix vs. Assembly Biosciences | Ocular Therapeutix vs. Spero Therapeutics | Ocular Therapeutix vs. Achilles Therapeutics PLC |
| Inozyme Pharma vs. Eliem Therapeutics | Inozyme Pharma vs. HCW Biologics | Inozyme Pharma vs. Scpharmaceuticals | Inozyme Pharma vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |